{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:54:08Z","timestamp":1790096048793,"version":"4.0.1"},"reference-count":24,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T00:00:00Z","timestamp":1568764800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["j. immunotherapy cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s40425-019-0736-4","type":"journal-article","created":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T14:07:31Z","timestamp":1568815651000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Tertiary lymphoid organs in the inflammatory myopathy associated with PD-1 inhibitors"],"prefix":"10.1136","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2519-5700","authenticated-orcid":false,"given":"Shiro","family":"Matsubara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morinobu","family":"Seki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeaki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Komori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikio","family":"Takamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,9,18]]},"reference":[{"key":"736_CR1","doi-asserted-by":"publisher","first-page":"809","DOI":"10.2217\/imt-2016-0001","volume":"8","author":"M Janakiram","year":"2016","unstructured":"Janakiram M, Pareek V, Cheng VH, Narasimhulu DM, Zang X. Immune checkpoint blockade in human cancer therapy: lung cancer and hematologic malignancies. Immunotherapy. 2016;8:809\u201319.","journal-title":"Immunotherapy."},{"key":"736_CR2","doi-asserted-by":"publisher","first-page":"e985","DOI":"10.1212\/WNL.0000000000006124","volume":"91","author":"M Touat","year":"2018","unstructured":"Touat M, Maisonobe T, Knauss S, Ben H, Salem O, Hervier BB, et al. Immune checkpoint inhibitor-related myositis and myocarditis in patients with cancer. Neurology. 2018;91:e985\u201394.","journal-title":"Neurology"},{"key":"736_CR3","doi-asserted-by":"publisher","unstructured":"Seki M, Uruha A, Ohnuki Y, Kamada S, Noda T, Onda A, et al. Inflammatory myopathy associated with PD-1 inhibitor. J Autoimmunity. 2019. https:\/\/doi.org\/10.1016\/j.aut.2019.03.005 .","DOI":"10.1016\/j.aut.2019.03.005"},{"key":"736_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.imlet.2007.06.009","volume":"112","author":"R Pabst","year":"2007","unstructured":"Pabst R. Plasticity and heterogeneity of lymphoid organs. What are the criteria to call a lymphoid organ primary, secondary or tertiary? Immunol Lett. 2007;112:1\u20138.","journal-title":"Immunol Lett"},{"key":"736_CR5","doi-asserted-by":"publisher","first-page":"7114","DOI":"10.1038\/ncomms8114","volume":"6","author":"JD Peske","year":"2015","unstructured":"Peske JD, Thompson ED, Gemta L, Baylis RA, Fu YX, Engelhard VH. Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunity. Nat Commun. 2015;6:7114. https:\/\/doi.org\/10.1038\/ncomms8114 .","journal-title":"Nat Commun"},{"key":"736_CR6","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nri2297","volume":"8","author":"R Forster","year":"2008","unstructured":"Forster R, Davalos-Misslitz AC, Rot A. CCR7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol. 2008;8:362\u201371.","journal-title":"Nat Rev Immunol."},{"key":"736_CR7","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","volume":"362","author":"MC Dalakas","year":"2003","unstructured":"Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet. 2003;362:971\u201382.","journal-title":"Lancet."},{"key":"736_CR8","doi-asserted-by":"crossref","unstructured":"Lundberg IE, Tjarnlund A, Bottai M, Werth VP, Pilkington C, Visser M et al. 2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis. 2017;76:1955\u20131964.","DOI":"10.1136\/annrheumdis-2017-211468"},{"key":"736_CR9","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.nmd.2018.01.004","volume":"28","author":"S Matsubara","year":"2018","unstructured":"Matsubara S, Bokuda K, Asano Y, Morishima R, Sugaya K, Miyamoto K, et al. Mitophagy in three cases of immune-mediated necrotizing myopathy associated with anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase autoantibodies: ultrastructural and immunohistochemical studies. Neuromuscul Disord. 2018;28:283\u20138.","journal-title":"Neuromuscul Disord"},{"key":"736_CR10","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00022744-200106000-00003","volume":"9","author":"E Bagdi","year":"2001","unstructured":"Bagdi E, Krenacs L, Krenacs T, Miller K, Isaacson PG. Follicular dendritic cells in reactive and neoplastic lymphoid tissues. A reevaluation of staining patterns of CD21, CD23, and CD35 antibodies in paraffin sections after wet heat-induced epitope retrieval. Appl Immunohistochem Mol Morphol. 2001;9:117\u201324.","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"736_CR11","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1038\/nprot.2014.163","volume":"9","author":"RC Melo","year":"2014","unstructured":"Melo RC, Morgan E, Monahan-Earley R, Dvorak AM, Weller PF. Pre-embedding immunogold labeling to optimize protein localization at subcellular compartments and membrane microdomains of leukocytes. Nat Protoc. 2014;9:2382\u201394.","journal-title":"Nat Protoc"},{"key":"736_CR12","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.immuni.2015.12.022","volume":"44","author":"J Cupovic","year":"2016","unstructured":"Cupovic J, Onder L, Gil-Cruz C, Weiler E, Caviezel-Firner S, Perez-Shibayama C, et al. Central nervous system stromal cells control local CD8(+) T cell responses during virus-induced neuroinflammation. Immunity. 2016;44:622\u201333.","journal-title":"Immunity."},{"key":"736_CR13","first-page":"1219","volume":"52","author":"E Mandache","year":"2011","unstructured":"Mandache E, Penescu M. Renal subcapsular tertiary lymphoid aggregates in chronic kidney diseases. Romanian J Morphol Embryol. 2011;52:1219\u201325.","journal-title":"Romanian J Morphol Embryol"},{"key":"736_CR14","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1111\/tri.12358","volume":"27","author":"T Hautz","year":"2014","unstructured":"Hautz T, Zelger BG, Nasr IW, Mundinger GS, Barth RN, Rodriguez ED, et al. Lymphoid neogenesis in skin of human hand, nonhuman primate, and rat vascularized composite allografts. Transpl Int. 2014;27:966\u201376.","journal-title":"Transpl Int"},{"key":"736_CR15","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1365-3083.1974.tb01260.x","volume":"3","author":"N Soderstrom","year":"1974","unstructured":"Soderstrom N, Biorklund A. Organization of the invading lymphoid tissue in human lymphoid thyroiditis. Scand J Immunol. 1974;3:295\u2013301.","journal-title":"Scand J Immunol"},{"key":"736_CR16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nri1786","volume":"6","author":"F Aloisi","year":"2006","unstructured":"Aloisi F, Pujol-Borrell R. Lymphoid neogenesis in chronic inflammatory diseases. Nat Rev Immunol. 2006;6:205\u201317.","journal-title":"Nat Rev Immunol"},{"key":"736_CR17","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1002\/art.22558","volume":"56","author":"CM Lopez De Padilla","year":"2007","unstructured":"Lopez De Padilla CM, Vallejo AN, McNallan KT, Vehe R, Smith SA, Dietz AB, et al. Plasmacytoid dendritic cells in inflamed muscle of patients with juvenile dermatomyositis. Arthritis Rheum. 2007;56:1658\u201368.","journal-title":"Arthritis Rheum"},{"key":"736_CR18","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1002\/art.24411","volume":"60","author":"CM Lopez De Padilla","year":"2009","unstructured":"Lopez De Padilla CM, Vallejo AN, Lacomis D, McNallan K, Reed M. Extranodal lymphoid microstructures in inflamed muscle and disease severity of new-onset juvenile dermatomyositis. Arthritis Rheum. 2009;60:1160\u201372.","journal-title":"Arthritis Rheum"},{"key":"736_CR19","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.1200\/JCO.2007.15.0284","volume":"26","author":"MC Dieu-Nosjean","year":"2008","unstructured":"Dieu-Nosjean MC, Antoine M, Danel C, Heudes D, Wislez M, Poulot V, et al. Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. J Clin Oncol. 2008;26:4410\u20137.","journal-title":"J Clin Oncol"},{"key":"736_CR20","doi-asserted-by":"publisher","first-page":"830","DOI":"10.3389\/fimmu.2017.00830","volume":"8","author":"JL Teillaud","year":"2017","unstructured":"Teillaud JL, Dieu-Nosjean MC. Tertiary lymphoid structures: an anti-tumor school for adaptive immune cells and an antibody factory to fight cancer? Front Immunol. 2017;8:830.","journal-title":"Front Immunol"},{"key":"736_CR21","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1093\/brain\/102.4.701","volume":"102","author":"S Matsubara","year":"1979","unstructured":"Matsubara S, Mair WG. Ultrastructural changes in polymyositis. Brain. 1979;102:701\u201325.","journal-title":"Brain."},{"key":"736_CR22","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/ana.410160206","volume":"16","author":"K Arahata","year":"1984","unstructured":"Arahata K, Engel AG. Monoclonal antibody analysis of mononuclear cells in myopathies. I: quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol. 1984;16:193\u2013208.","journal-title":"Ann Neurol"},{"key":"736_CR23","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1084\/jem.20092454","volume":"207","author":"ED Thompson","year":"2010","unstructured":"Thompson ED, Enriquez HL, Fu YX, Engelhard VH. Tumor masses support naive T cell infiltration, activation, and differentiation into effectors. J Exp Med. 2010;207:1791\u2013804.","journal-title":"J Exp Med"},{"key":"736_CR24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/ni1029","volume":"5","author":"P Yu","year":"2004","unstructured":"Yu P, Lee Y, Liu W, Chin RK, Wang J, Wang Y, et al. Priming of naive T cells inside tumors leads to eradication of established tumors. Nat Immunol. 2004;5:141\u20139.","journal-title":"Nat Immunol"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40425-019-0736-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40425-019-0736-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40425-019-0736-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:01:27Z","timestamp":1664409687000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1186\/s40425-019-0736-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,18]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["736"],"URL":"https:\/\/doi.org\/10.1186\/s40425-019-0736-4","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,18]]},"assertion":[{"value":"14 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors contributed to this study, read the final version of this manuscript and approved its publication.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicting interest regarding the present study except Dr. Suzuki who is a consultant\/advisory board member on neurologic side effects for Ono Pharmaceutical Company, Bristol-Myers Squibb and MSD.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"256"}}